Phunuch Muhamad

Phunuch Muhamad

Auto-generated profile, based on publicly available information

Phunuch Muhamad

Drug Discovery and Development Center, Office of Advanced Science and Technology, Thammasat University, Pathumtani 12120, Thailand

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Journal of Pharmacological Sciences
Verified
Journal Article
Open access
KKKanawut Kotawong
Kanawut Kotawong
WCWanna Chaijaroenkul
Wanna Chaijaroenkul
PMPhunuch Muhamad
Phunuch Muhamad
KNKesara Na-Bangchang
Kesara Na-Bangchang
Cholangiocarcinoma (CCA) is the cancer of bile duct with high mortality rate particularly in Thailand. The clinical efficacy of the standard chemotherapeutics remains unsatisfactory, and therefore, discovery and development of the new alternative drugs with high efficacy and tolerability is needed. The aim of the study was to investigate cytotoxic activity as well as the underlying mechanisms through which atractylodin and β-eudesmol exert their activities on CCA cell growth inhibition, cell cycle arrest, and cell apoptosis. Effects of the compounds on cell cytotoxicity, cell cycle arrest, and cell apoptosis were analyzed using MTT assay, BD Cycletest™ Plus DNA kit, and FITC Annexin V Apoptosis Detection Kit I, respectively. The cytotoxic activities of both compounds were concentration- and time-dependent. The IC50 [mean (SD)] of atractylodin and β-eudesmol were 41.66 (2.51) and 39.33 (1.15) μg/ml respectively. Both promoted cell cycle arrest at G1 phase, and induced cell apoptosis through activation of caspase-3/7. The highest activity was observed at 48 h of exposure. Results suggest that these mechanisms are at least in part, explain the cell cytotoxic and anti-CCA activity of atractylodin and β-eudesmol shown in vitro and in vivo models.

30 July 2013 in Malaria Journal
Verified
Journal Article
Open access
PDF file
KNKesara Na-Bangchang
Kesara Na-Bangchang
PMPhunuch Muhamad
Phunuch Muhamad
RRRonnatrai Ruaengweerayut
Ronnatrai Ruaengweerayut
WCWanna Chaijaroenkul
Wanna Chaijaroenkul
JKJuntra Karbwang
Juntra Karbwang
A markedly high failure rate of three-day artesunate-mefloquine was observed in the area along the Thai-Myanmar border.

6 December 2018 in Journal of Tropical Medicine
Verified
Journal Article
Open access
PDF file
ATArtitaya Thiengsusuk
Artitaya Thiengsusuk
PMPhunuch Muhamad
Phunuch Muhamad
WCWanna Chaijaroenkul
Wanna Chaijaroenkul
KNKesara Na-Bangchang
Kesara Na-Bangchang
Malaria remains a public health problem in tropical and subtropical regions. Resistance of Plasmodium falciparum to artemisinins in Southeast Asia is a great concern for disease control and research on discovery and development of new alternative antimalarial drugs is urgently required. In a previous study, the fruit of Piper chaba Hunt. was demonstrated to exhibit promising antimalarial activity against the asexual stage of 3D7 (chloroquine-sensitive) and K1 (chloroquine-resistant) P. falciparum clones. The aim of the present study was to further investigate the antimalarial activity of piperine, the major isolated constituent of Piper chaba Hunt. fruits against both P. falciparum clones. The antimalarial activity was determined using SYBR green-I-based assay and morphological change was observed under the light microscope with Giemsa staining. The median IC50 (concentration that inhibits parasite growth by 50%) values of piperine against 3D7 and K1 P. falciparum were 111.5 and 59 μM, respectively. A marked change in parasite morphology was observed within 48 hours of piperine exposure. Results of real-time PCR showed no effect of piperine on modulating the expression of the three genes associated with antimalarial drug resistance in P. falciparum, i.e., pfcrt, pfmdr1, and pfmrp1. Piperine could be a promising candidate for further development as an antimalarial drug based on its antimalarial potency and low risk of resistance development.

15 January 2014 in Malaria Journal
Verified
Journal Article
Open access
PDF file
PPPapichaya Phompradit
Papichaya Phompradit
PMPoonuch Muhamad
Poonuch Muhamad
RWRaewadee Wisedpanichkij
Raewadee Wisedpanichkij
WCWanna Chaijaroenkul
Wanna Chaijaroenkul
KNKesara Na-Bangchang
Kesara Na-Bangchang
The decline in efficacy of artesunate (AS) and mefloquine (MQ) is now the major concern in areas along the Thai-Cambodian and Thai-Myanmar borders.

1 October 2018 in Journal of Experimental Pharmacology
Verified
Journal Article
Open access
PDF file
Pongsakorn MartvisetPongsakorn Martviset
Pongsakorn Martviset
WCWanna Chaijaroenkul
Wanna Chaijaroenkul
PMPhunuch Muhamad
Phunuch Muhamad
KNKesara Na-Bangchang
Kesara Na-Bangchang
Background: Cholangiocarcinoma (CCA) is the primary type of bile duct cancer with high morbidity and mortality, particularly in patients with advanced-stage disease. Treatment of CCA remains unsatisfactory due to the lack of sensitive and specific diagnostic tool for early detection as well as effective chemotherapeutics. Purpose: To investigate cytotoxic interactions between the three major constituents of the rhizomes of Atractylodes lancea (Thunb.) DC., ie, β-eudesmol (BE), atractylodin (AT), and hinesol (HS), against CCA cell line. Methods: Cytotoxic activities against the human CCA cells CL-6 of the dual (BE:AT, BE:HS, and AT:HS) and triple (BE:AT:HS) combinations were evaluated using MTT assay. The cytotoxic interaction of each dual combination was assessed at five concentration ratios (10:0, 7:3, 5:5, 3:7, and 0:10) using isobologram analysis. For triple combination, the concentration ratio used in the experiment was 1:1.5:2.5 (BE:AT:HS) and analysis of the interaction was performed using polygonogram analysis at the concentrations that inhibit cell growth by 50% and 90%, respectively. Results: The BE:AT combination produced the additive effect with sum fractional inhibitory concentration of 0.967±0.02 (mean ± SD). The BE:HS and AT:HS combinations produced a synergistic effect with sum fractional inhibitory concentrations of 0.685±0.08 and 0.767±0.09, respectively. The mixture of the three compounds produced synergistic interaction with combination index values of 0.519±0.10 and 0.65±0.17 (mean ± SD) at the concentrations that inhibit cell growth at the 50% and 90% leveled, respectively. Conclusion: Results obtained would guide further development of Atractylodes lancea (Thunb.) DC. as potential anti-CCA chemotherapeutics concerning the appropriate pharmaceutical dosage form.

16 February 2011 in Malaria Journal
Verified
Journal Article
Open access
PDF file
PMPoonuch Muhamad
Poonuch Muhamad
RRRonnatrai Ruengweerayut
Ronnatrai Ruengweerayut
WCWanna Chaijaroenkul
Wanna Chaijaroenkul
KRKanchana Rungsihirunrat
Kanchana Rungsihirunrat
KNKesara Na-Bangchang
Kesara Na-Bangchang
Background: In Thailand, the proportion of Plasmodium vivax infection has become equal to Plasmodium falciparum. Reports of a trend of gradual decline of in vitro sensitivity of P. vivax to chloroquine in some areas of the country, together with accumulating evidences of chloroquine resistance P. vivax in other parts of the world, emphasize the need for closely and continuously monitoring clinical efficacy in conjunction with in vitro sensitivity of P. vivax isolates. Methods: The study was conducted at Mae Tao clinic for migrant workers, Tak Province during March 2008 - August 2009. A total of 130 patients (17 Thais and 113 Burmeses; 64 males and 66 females) with mono-infection of P. vivax malaria, aged between 15-60 years and weighing more than 40 kg, were included in the study. Patients received treatment with chloroquine (2,000 mg chloroquine phosphate over three days) and the anti-relapse drug primaquine (15 mg for 14 days). In vitro sensitivity of P. vivax isolates was evaluated by schizont maturation inhibition assay. Results: All patients showed satisfactory response to treatment. The cure rate was virtually 100% within the follow-up period of 42 days. Neither recurrence of P. vivax parasitaemia nor appearance of P. falciparum occurred during the investigation period. In vitro data showed a stable sensitivity of chloroquine in this area since 2006. Geometric mean and median (95% CI) values of IC50 for chloroquine were 100.1 and 134.7 (1.1-264.9) nM, respectively. Conclusion: In vivo results suggest that the standard regimen of chloroquine was still very effective for the treatment of blood infections with P. vivax in the Thai-Myanmar border area. In vitro sensitivity data however, raise the possibility of potential advent of resistance in the future. Regular monitoring of the chloroquine sensitivity of P. vivax is essential to facilitate the early recognition of treatment failures and to expedite the formulation of appropriate changes to the drug policy.